Efficacy and Hematologic Toxicity of Salvage Chemotherapy Following Stem Cell-Supported High-Dose Chemotherapy in Women with Recurrent Ovarian Cancer

By Cook S.   Penson R.   Duska L.   Nikrui N.   Goodman A.   Fuller A.   Seiden M.  

Gynecologic Oncology, Vol. 77, Iss. 1, 2000-04 ,pp. : 48-54

Elsevier

Access to resources Recommend Favorite

The Toxicity of Radiotherapy Following High-dose Chemotherapy With Peripheral Blood Stem Cell Support in High-risk Breast Cancer: A Preliminary Analysis

By van der Wall E.   Schaake-Koning C.C.E.   van Zandwijk N.   Baars J.W.   Schornagel J.H.   Richel D.J.   Rutgers E.J.T.   Borger J.H.   Beijnen J.H.   Rodenhuis S.  

European Journal of Cancer, Vol. 32, Iss. 9, 1996-08 ,pp. : 1490-1497

Elsevier

Access to resources Recommend Favorite

Acute and Late Toxicity Following Adjuvant High-Dose Chemotherapy for High-Risk Primary Operable Breast Cancer A Quality Assessment Study

By Svane Inge M.   Homburg Keld M.   Kamby Claus   Nielsen Dorte L.   Roer Ole   Sliffsgaard Dorte   Johnsen Hans E.   Hansen Steen W.  

Acta Oncologica, Vol. 41, Iss. 7-8, 2002-11 ,pp. : 675-683

Informa Healthcare

Access to resources Recommend Favorite

Increased frequencies of memory and activated B cells and follicular helper T cells are positively associated with high levels of activationinduced cytidine deaminase in patients with immunoglobulin A nephropathy

By        

Molecular Medicine Reports, Vol. 12, Iss. 4, 2015-01 ,pp. : 5531-5537

Spandidos Publications

Access to resources Recommend Favorite

A Phase I Toxicity and Feasibility Trial of Sequential Dose-Dense Induction Chemotherapy with Doxorubicin, Paclitaxel, and 5-Fluorouracil Followed by High Dose Consolidation for High-Risk Primary Breast Cancer

By Emens L.A.   Kennedy M.J.   Fetting J.H.   Davidson N.E.   Garrett E.   Armstrong D.K.  

Breast Cancer Research and Treatment, Vol. 76, Iss. 2, 2002-11 ,pp. : 145-156

Springer Publishing Company

Access to resources Recommend Favorite